Tumor necrosis factor system in insulin resistance in gestational diabetes
- 1 May 2002
- journal article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 56 (2), 93-99
- https://doi.org/10.1016/s0168-8227(01)00355-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Plasma Levels of Tumor Necrosis Factor-α, Angiotensin II, Growth Hormone, and IGF-I Are Not Elevated in Insulin-Resistant Obese Individuals With Impaired Glucose ToleranceDiabetes Care, 2001
- CYTOKINE RELEASE FROM PLACENTAL ENDOTHELIAL CELLS, A PROCESS ASSOCIATED WITH PRETERM LABOUR IN THE ABSENCE OF INTRAUTERINE INFECTIONCytokine, 1999
- Mechanisms of TNF-α-induced insulin resistanceExperimental and Clinical Endocrinology & Diabetes, 1999
- An in Vivo Model for Elucidation of the Mechanism of Tumor Necrosis Factor- (TNF- )-Induced Insulin Resistance: Evidence for Differential Regulation of Insulin Signaling by TNF-Endocrinology, 1998
- Increased circulating cytokine receptors and ex vivo interleukin‐1 receptor antagonist and interleukin‐1β production but decreased tumour necrosis factor‐α production after a 5‐km runEuropean Journal of Clinical Investigation, 1998
- The expression of TNF alpha by human muscle. Relationship to insulin resistance.JCI Insight, 1996
- The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.JCI Insight, 1995
- Tumor necrosis factor alpha: a key component of the obesity-diabetes linkDiabetes, 1994
- Longitudinal changes in insulin release and insulin resistance in nonobese pregnant womenAmerican Journal of Obstetrics and Gynecology, 1991
- Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetesAmerican Journal of Obstetrics and Gynecology, 1990